Screener
Crinetics Pharmaceuticals CRNX Business Segments — Research And Development Personnel Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept crnx:ResearchAndDevelopmentPersonnelExpenses.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Paltusotine | (11,869) | (17,251) |
| Atumelnant | (20,267) | (7,749) |
| Other research and development programs | (9,667) | (7,058) |
| Research and development personnel expenses | (30,649) | (25,627) |
| Research and development stock-based compensation | (19,328) | (11,819) |
| Other research and development (1) | (8,301) | (6,736) |
| Total research and development expenses | (100,081) | (76,240) |
| Selling, general and administrative |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Crinetics Pharmaceuticals's business segments — research and development personnel expenses?
- Crinetics Pharmaceuticals (CRNX) reported business segments — research and development personnel expenses of $30.65M in Q1 2026.
- How has Crinetics Pharmaceuticals's business segments — research and development personnel expenses changed year-over-year?
- Crinetics Pharmaceuticals's business segments — research and development personnel expenses increased by 19.6% year-over-year, from $25.63M to $30.65M.
- What does business segments — research and development personnel expenses mean?
- This metric represents the total compensation and benefits costs for employees directly involved in research and development activities. It serves as a proxy for the company's internal scientific capacity and human capital investment. Monitoring this helps assess the scale and growth of the organization's R&D workforce.
Ask your AI about Crinetics Pharmaceuticals's business segments — research and development personnel expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude